AU2013207589A1 - Anti-Siglec-15 Antibody - Google Patents
Anti-Siglec-15 AntibodyInfo
- Publication number
- AU2013207589A1 AU2013207589A1 AU2013207589A AU2013207589A AU2013207589A1 AU 2013207589 A1 AU2013207589 A1 AU 2013207589A1 AU 2013207589 A AU2013207589 A AU 2013207589A AU 2013207589 A AU2013207589 A AU 2013207589A AU 2013207589 A1 AU2013207589 A1 AU 2013207589A1
- Authority
- AU
- Australia
- Prior art keywords
- siglec
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004965 antibodies Human genes 0.000 title 1
- 108090001123 antibodies Proteins 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2013207589A AU2013207589B2 (en) | 2009-04-09 | 2013-07-17 | Anti-Siglec-15 Antibody |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009-094613 | 2009-04-09 | ||
JP2009094613 | 2009-04-09 | ||
AU2010235453A AU2010235453B2 (en) | 2009-04-09 | 2010-04-07 | Anti-Siglec-15 antibody |
AU2013207589A AU2013207589B2 (en) | 2009-04-09 | 2013-07-17 | Anti-Siglec-15 Antibody |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2010235453A Division AU2010235453B2 (en) | 2009-04-09 | 2010-04-07 | Anti-Siglec-15 antibody |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2013207589A1 true AU2013207589A1 (en) | 2013-08-08 |
AU2013207589B2 AU2013207589B2 (en) | 2016-04-07 |
Family
ID=42936292
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2010235453A Ceased AU2010235453B2 (en) | 2009-04-09 | 2010-04-07 | Anti-Siglec-15 antibody |
AU2013207589A Ceased AU2013207589B2 (en) | 2009-04-09 | 2013-07-17 | Anti-Siglec-15 Antibody |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2010235453A Ceased AU2010235453B2 (en) | 2009-04-09 | 2010-04-07 | Anti-Siglec-15 antibody |
Country Status (19)
Country | Link |
---|---|
US (3) | US8575316B2 (en) |
EP (2) | EP2377932B1 (en) |
JP (2) | JP5653909B2 (en) |
KR (1) | KR101690340B1 (en) |
CN (2) | CN106317224B (en) |
AU (2) | AU2010235453B2 (en) |
BR (1) | BRPI1006134A2 (en) |
CA (1) | CA2750836C (en) |
CO (1) | CO6420359A2 (en) |
ES (1) | ES2840923T3 (en) |
IL (2) | IL213943A (en) |
MX (2) | MX2011007342A (en) |
MY (1) | MY152033A (en) |
NZ (2) | NZ605450A (en) |
RU (2) | RU2539790C2 (en) |
SG (2) | SG172419A1 (en) |
TW (1) | TWI468177B (en) |
WO (1) | WO2010117011A1 (en) |
ZA (1) | ZA201104545B (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8168181B2 (en) * | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
US7989160B2 (en) | 2006-02-13 | 2011-08-02 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
ES2540733T3 (en) * | 2007-10-11 | 2015-07-13 | Daiichi Sankyo Company, Limited | Antibody that targets Siglec-15 osteoclast-related protein |
MX2011007342A (en) | 2009-04-09 | 2011-07-21 | Daiichi Sankyo Co Ltd | ANTI-Siglec-15 ANTIBODY. |
JP2013543382A (en) | 2010-10-05 | 2013-12-05 | 第一三共株式会社 | Antibodies targeting the osteoclast-related protein Siglec-15 |
JP6216317B2 (en) * | 2011-09-09 | 2017-10-18 | メディミューン リミテッド | Anti-Siglec-15 antibody and use thereof |
CA2868959A1 (en) * | 2012-03-30 | 2013-10-03 | Daiichi Sankyo Company, Limited | Cdr-modified anti-siglec-15 antibody |
MX2014011826A (en) * | 2012-03-30 | 2014-11-21 | Daiichi Sankyo Co Ltd | Novel anti-siglec15 antibody. |
EP2875051B1 (en) | 2012-07-19 | 2019-02-20 | Daiichi Sankyo Company, Limited | Anti-siglec-15 antibodies |
SG11201602490UA (en) | 2013-09-30 | 2016-04-28 | Daiichi Sankyo Co Ltd | Anti-lps o11 antibody |
US20170129956A1 (en) * | 2014-06-18 | 2017-05-11 | Daiichi Sankyo Company, Limited | Anti-siglec-15 antibodies for use in treatment of osteogenesis imperfecta |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
AU2016286898B2 (en) | 2015-06-29 | 2022-12-08 | Daiichi Sankyo Company, Limited | Method for selectively manufacturing antibody-drug conjugate |
RU2759334C2 (en) | 2016-09-21 | 2021-11-12 | Нексткьюр, Инк. | Antibodies against siglec-15 and their application methods |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
TWI782000B (en) | 2017-03-30 | 2022-11-01 | 日商第一三共股份有限公司 | Anti gpr20 antibodies, preparation method and application thereof |
CN110913905A (en) * | 2017-06-30 | 2020-03-24 | 国立大学法人北海道大学 | Therapeutic agent for infantile osteoporosis without growth disturbance |
JP7271424B2 (en) | 2017-07-27 | 2023-05-11 | 第一三共株式会社 | Anti-CD147 antibody |
JP6790307B2 (en) | 2018-05-31 | 2020-11-25 | 第一三共株式会社 | Anti-human TLR7 antibody |
KR20210040059A (en) | 2018-07-27 | 2021-04-12 | 다이이찌 산쿄 가부시키가이샤 | Protein Recognizing the Drug Site of an Antibody-Drug Conjugate |
CN111378043B (en) * | 2020-02-19 | 2021-02-09 | 南京医科大学 | Human-mouse chimeric anti-Siglec-15 whole-molecule IgG with neutralization function and preparation method and application thereof |
CN113817057B (en) * | 2020-06-19 | 2024-02-20 | 盛禾(中国)生物制药有限公司 | Anti-siglec 15 antibody and application thereof |
CN112159475B (en) * | 2020-10-10 | 2021-04-30 | 南京凯地生物科技有限公司 | Siglec-15 monoclonal antibody and application thereof |
WO2022228183A1 (en) * | 2021-04-30 | 2022-11-03 | 杭州邦顺制药有限公司 | Anti-siglec15 antibody, preparation method therefor and use thereof |
CN113577283A (en) * | 2021-07-19 | 2021-11-02 | 河北医科大学第三医院 | Application of Siglec-15 inhibitor in preparation of medicines for preventing and treating giant cell tumor of bone |
CN114807052A (en) * | 2022-06-07 | 2022-07-29 | 江苏亲科生物研究中心有限公司 | SIGLEC15 monoclonal antibody, preparation method and application thereof |
WO2024040195A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
CA2109602C (en) | 1990-07-10 | 2002-10-01 | Gregory P. Winter | Methods for producing members of specific binding pairs |
WO1993006213A1 (en) | 1991-09-23 | 1993-04-01 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
ATE275198T1 (en) | 1991-12-02 | 2004-09-15 | Medical Res Council | PRODUCTION OF ANTIBODIES ON PHAGE SURFACES BASED ON ANTIBODIES SEGMENT LIBRARIES. |
JP3507073B2 (en) | 1992-03-24 | 2004-03-15 | ケンブリッジ アンティボディー テクノロジー リミティド | Methods for producing members of a specific binding pair |
GB9313509D0 (en) | 1993-06-30 | 1993-08-11 | Medical Res Council | Chemisynthetic libraries |
AU690171B2 (en) | 1993-12-03 | 1998-04-23 | Medical Research Council | Recombinant binding proteins and peptides |
IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
DE19653646A1 (en) | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituted purine derivatives, processes for their preparation, agents containing them and their use |
HU229476B1 (en) | 1997-04-15 | 2014-01-28 | Daiichi Sankyo Company | Antibodies against obm |
DK1071700T3 (en) | 1998-04-20 | 2010-06-07 | Glycart Biotechnology Ag | Glycosylation modification of antibodies to enhance antibody-dependent cellular cytotoxicity |
ES2420835T3 (en) | 1999-04-09 | 2013-08-27 | Kyowa Hakko Kirin Co., Ltd. | Procedure to control the activity of immunofunctional molecules |
BR0114475A (en) | 2000-10-06 | 2003-12-23 | Kyowa Hakko Kogyo Kk | Cell for the production of antibody composition |
US7608704B2 (en) | 2000-11-08 | 2009-10-27 | Incyte Corporation | Secreted proteins |
AU2002233994A1 (en) | 2000-11-08 | 2002-05-21 | Incyte Genomics, Inc. | Secreted proteins |
WO2002064771A1 (en) | 2001-02-15 | 2002-08-22 | Mochida Pharmaceutical Co., Ltd. | Novel cell adhesion molecule specific to activated leukocyte |
PT2087908T (en) | 2001-06-26 | 2018-07-16 | Amgen Inc | Antibodies to opgl |
AU2002364699A1 (en) | 2001-11-13 | 2003-06-17 | Incyte Genomics, Inc. | Receptors and membrane-associated proteins |
US7193069B2 (en) | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
EP1494714A4 (en) | 2002-04-05 | 2008-03-05 | Amgen Inc | Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors |
DE602004002275T2 (en) | 2003-01-07 | 2007-09-06 | Symphogen A/S | PROCESS FOR PRODUCING RECOMBINANT POLYCLONAL PROTEINS |
TWI359026B (en) | 2004-02-12 | 2012-03-01 | Sankyo Co | Pharmaceutical composition for the osteoclast rela |
US7405037B2 (en) | 2004-05-07 | 2008-07-29 | Lonza Walkersville, Inc. | Methods and tools for detecting collagen degradation |
JP4604184B2 (en) * | 2005-07-12 | 2010-12-22 | 独立行政法人産業技術総合研究所 | Novel sugar chain recognition protein and its gene |
US7989160B2 (en) | 2006-02-13 | 2011-08-02 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
ES2540733T3 (en) | 2007-10-11 | 2015-07-13 | Daiichi Sankyo Company, Limited | Antibody that targets Siglec-15 osteoclast-related protein |
MX2011007342A (en) | 2009-04-09 | 2011-07-21 | Daiichi Sankyo Co Ltd | ANTI-Siglec-15 ANTIBODY. |
-
2010
- 2010-04-07 MX MX2011007342A patent/MX2011007342A/en active IP Right Grant
- 2010-04-07 SG SG2011047412A patent/SG172419A1/en unknown
- 2010-04-07 BR BRPI1006134A patent/BRPI1006134A2/en not_active Application Discontinuation
- 2010-04-07 NZ NZ605450A patent/NZ605450A/en not_active IP Right Cessation
- 2010-04-07 MY MYPI2011002935 patent/MY152033A/en unknown
- 2010-04-07 MX MX2014002553A patent/MX343049B/en unknown
- 2010-04-07 EP EP10761710.2A patent/EP2377932B1/en active Active
- 2010-04-07 WO PCT/JP2010/056294 patent/WO2010117011A1/en active Application Filing
- 2010-04-07 RU RU2011128332/10A patent/RU2539790C2/en active
- 2010-04-07 JP JP2011508375A patent/JP5653909B2/en active Active
- 2010-04-07 EP EP20165057.9A patent/EP3699277A1/en not_active Withdrawn
- 2010-04-07 US US13/143,253 patent/US8575316B2/en active Active
- 2010-04-07 CA CA2750836A patent/CA2750836C/en active Active
- 2010-04-07 ES ES10761710T patent/ES2840923T3/en active Active
- 2010-04-07 SG SG10201401331TA patent/SG10201401331TA/en unknown
- 2010-04-07 NZ NZ593550A patent/NZ593550A/en not_active IP Right Cessation
- 2010-04-07 CN CN201610749543.2A patent/CN106317224B/en not_active Expired - Fee Related
- 2010-04-07 CN CN201080004195.7A patent/CN102272306B/en not_active Expired - Fee Related
- 2010-04-07 KR KR1020117015666A patent/KR101690340B1/en active IP Right Grant
- 2010-04-07 AU AU2010235453A patent/AU2010235453B2/en not_active Ceased
- 2010-04-08 TW TW99110882A patent/TWI468177B/en not_active IP Right Cessation
-
2011
- 2011-06-20 ZA ZA2011/04545A patent/ZA201104545B/en unknown
- 2011-07-05 IL IL213943A patent/IL213943A/en active IP Right Grant
- 2011-07-08 CO CO11085127A patent/CO6420359A2/en active IP Right Grant
-
2013
- 2013-07-17 AU AU2013207589A patent/AU2013207589B2/en not_active Ceased
- 2013-09-30 US US14/041,479 patent/US9079959B2/en active Active
-
2014
- 2014-11-19 JP JP2014234461A patent/JP6210966B2/en active Active
- 2014-11-24 RU RU2014147188A patent/RU2014147188A/en not_active Application Discontinuation
-
2015
- 2015-06-05 US US14/731,519 patent/US9751944B2/en active Active
-
2017
- 2017-05-28 IL IL252561A patent/IL252561B/en active IP Right Grant
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013207589A1 (en) | Anti-Siglec-15 Antibody | |
ZA201104545B (en) | Anti-siglec-15 antibody | |
EP3514173B8 (en) | Dkk-1 antibodies | |
GB2473934B (en) | Anti-VEEV antibody | |
AU2009100824A4 (en) | Heslr | |
AU2009100437A4 (en) | Pippetop | |
AU2009100982A4 (en) | Flip - barbi | |
AU2009100147A4 (en) | Safetank | |
AU2009100564A4 (en) | Agwave | |
AU2009100680A4 (en) | Ezy-Lay | |
AU2009100423A4 (en) | Byak | |
AU2009100848A4 (en) | Headbags | |
AU2009100472A4 (en) | Duramind | |
AU2009100549A4 (en) | XBlend | |
AU2009100092A4 (en) | Interfilm | |
AU2009101028A4 (en) | Hybridtelerent | |
AU2009101120A4 (en) | Koolkilt | |
AU2009902142A0 (en) | Variant domain antibodies | |
GB0911712D0 (en) | Antibody | |
AU2009901647A0 (en) | Pumpbox | |
AU2009901036A0 (en) | e-AD | |
AU2009901509A0 (en) | Scoods | |
AU2009901345A0 (en) | Camsok | |
AU2009901319A0 (en) | Caralift | |
AU2009901300A0 (en) | Thermomoulding |